(ciprofloxacin otic solution) 0.2%
A single medicine with the power to soothe and the power to cure without a steroid
First and ONLY FDA approved single agent ciprofloxacin otic solution in the United States.
For additional information on CETRAXAL® please visit www.cetraxal.net
DOSAGE AND ADMINISTRATION
The contents of one single use vial should be instilled into the affected ear twice daily (approximately 12 hours apart) for 7 days.
CETRAXAL® is a sterile, preservative-free, otic solution of ciprofloxacin hydrochloride equivalent to 0.2% ciprofloxacin (0.5 mg in 0.25 mL) in each single use container.
Pregnancy Category C
14 single use containers are packaged in a foil overwrap pouch in a carton. Discard used containers. Store unused containers in pouch to protect from light.
NDC # 66992-450-14
See our Ad in the August and September editions of, The American Academy of Pediatrics
See our Ad in the February and March editions of, The American Academy of Otolaryngology 2010
SEE PACKAGE INSERT FOR FULL PRESCRIBING INFORMATION
CETRAXAL® is a registered trademark of Laboratorios Salvat, S.A